Hyperbaric oxygen therapy salvages compromised grafts and flaps
Hyperbaric oxygen therapy salvages compromised grafts and flaps
Why grafts and flaps fail and how oxygen therapy saves them
Skin grafts and surgical flaps can fail when the transplanted tissue does not receive adequate blood supply and oxygen to survive. Compromised grafts and flaps may show signs of discoloration, swelling, decreased temperature or tissue breakdown. Underlying conditions such as diabetes, radiation injury, infection and poor circulation increase the risk of failure.
Time is critical — the typical protocol for compromised grafts or flaps begins with two treatments per day to salvage as much tissue as early as possible. HBOT delivers 1,200% more oxygen to the threatened tissue, stimulates new blood vessel growth into the graft bed, enhances immune function and supports the collagen production needed for successful integration. Over 25 years, Bay Area Hyperbarics has achieved over 90% salvage success for referred graft and flap patients.
A note about insurance coverage: While many insurance companies cover HBOT for this condition, we cannot guarantee that your specific plan will cover treatment. Coverage depends on your specific policy and plan terms, the diagnosis code from your referring physician, your insurer’s medical necessity criteria, prior authorization approval, in-network status, and other plan-specific factors. Our Patient Care Coordinators will advocate on your behalf — please speak with them at or before your consultation so we can verify your benefits and avoid any surprises.
Graft or flap showing signs of compromise or failure
Discoloration, swelling or decreased tissue temperature
Underlying conditions impairing healing (diabetes, radiation, infection)
Risk of complete tissue loss requiring additional surgery
How pressurized oxygen saves compromised grafts and flaps
HBOT addresses every factor that causes grafts and flaps to fail — oxygen deprivation, poor blood supply, infection and inadequate tissue integration.
Increases graft and flap salvage rates to over 90%
Stimulates angiogenesis into the graft bed
Increases tissue oxygenation by 1,200%
Speeds ischemic tissue survival
Stimulates stem cell mobilization for tissue repair
Speeds surgical repair and collagen production
For Providers
Clinical evidence for HBOT in compromised graft and flap salvage
HBOT for compromised grafts and flaps is an FDA and Medicare-approved indication with a robust evidence base from randomized trials, controlled series and over 25 years of clinical experience at Bay Area Hyperbarics.
Perrins — randomized controlled trial (1967): The foundational RCT of HBOT for skin grafts, published in the British Journal of Plastic Surgery by D.J.D. Perrins, enrolled 48 patients with split-thickness skin grafts and randomized them to HBOT or standard care. The HBOT group achieved significantly better graft take rates — 64% of the HBOT-treated graft area survived versus 17% in controls. This dramatic difference established HBOT as a powerful salvage intervention for compromised grafts and informed the subsequent decades of clinical use. [Perrins DJ. Br J Plast Surg. 1967;20(4):380–395. PMID: 4867635]
Zamboni et al. — controlled study in compromised flaps (1993): A controlled laboratory and clinical study published in Plastic and Reconstructive Surgery demonstrated that HBOT significantly improved survival of compromised random pattern flaps, with the benefit attributed to enhanced oxygen delivery to the ischemic zone of the flap, VEGF-mediated angiogenesis and attenuation of ischemia-reperfusion injury at the flap margin. The study documented the dose-response relationship and timing requirements for maximum benefit. [Zamboni WA et al. Plast Reconstr Surg. 1993;91(6):1104–1116. PMID: 8479998]
Mathieu et al. — systematic review (2006): A systematic review of HBOT for compromised grafts and flaps published in Plastic and Reconstructive Surgery analyzed available controlled and observational data and concluded that HBOT significantly improves outcomes for compromised skin grafts and flaps, particularly when initiated early and used alongside appropriate surgical management. The review supported HBOT as a standard adjunct for threatened reconstructive tissue. [Mathieu D et al. Plast Reconstr Surg. 2006;117(7 Suppl):208S–213S. PMID: 16799383]
Angiogenesis mechanism: HBOT upregulates VEGF and activates endothelial progenitor cell homing to the ischemic graft or flap margin, driving neovascularization that progressively establishes permanent capillary connections between host bed and transplanted tissue. This angiogenic response extends beyond the ischemia-rescue phase, providing durable improvements in graft vascularity that continue to develop after HBOT ends.
Timing is critical: Published evidence and clinical experience consistently support that HBOT initiated early — ideally within 24 hours of graft or flap compromise, and with twice-daily sessions in the acute phase — produces the best outcomes. Our clinic achieves over 90% salvage success for referred compromised grafts and flaps over 25 years of practice.
Urgent treatment protocol for compromised grafts and flaps
Time is critical. Contact us immediately if your graft or flap shows signs of compromise.
Urgent assessment and coordinated surgical care
Our medical team evaluates the graft or flap status and coordinates with your surgeon to begin HBOT as quickly as possible to maximize tissue salvage.
Twice-daily HBOT sessions to salvage tissue
The typical protocol begins with two treatments per day during the acute phase, then transitions to daily sessions. Each session involves breathing 100% oxygen for approximately 90 minutes.
Progressive tissue integration and surgical success
We monitor graft viability throughout treatment. Most patients see progressive improvement in tissue color, temperature and integration as new blood vessels establish.
Frequently Asked Questions
Answers to the questions patients ask most about hyperbaric oxygen therapy for compromised grafts and flaps.
HBOT delivers 1,200% more oxygen to the compromised tissue, sustaining cell viability while stimulating new blood vessel growth into the graft bed. This dual mechanism preserves tissue that would otherwise die and establishes the permanent blood supply needed for successful integration.
Graft or flap failing? Contact us immediately
Time is critical for saving compromised tissue. Call Bay Area Hyperbarics to begin urgent HBOT treatment and maximize your graft or flap salvage.
